TY - JOUR
T1 - Induction of antioxidant and detoxification response by oxidants in cardiomyocytes
T2 - Evidence from gene expression profiling and activation of Nrf2 transcription factor
AU - Purdom-Dickinson, Sally E.
AU - Lin, Yan
AU - Dedek, Matt
AU - Morrissy, Steve
AU - Johnson, Jeffery
AU - Chen, Qin M.
N1 - Funding Information:
Works from our laboratory have been supported by the Burroughs Wellcome Foundation, American Heart Association, American Federation for Aging Research, Arizona Disease Control Research Commission, NIH R01 ES010826 and NIH RO1 HL076530-01 (QMC). We thank the Genomics Core facility of Arizona Cancer Center and Southwest Environmental Health Sciences Center (ES06694) for Microarray Analyses. We thank Dr. David Ross for NQO1 antibody. Sally Purdom was supported by NIH T32 ES007091.
PY - 2007/1
Y1 - 2007/1
N2 - Mild or low doses of oxidants are known to prime cells towards resistance against further damage. In cardiomyocytes, we found that pretreatment with 100 μM H2O2 prevents the cells from apoptosis induced by doxorubicin (Dox). Affymetrix microarray analyses of 28,000 genes reveal that H2O2 treated cells reduced expression of genes encoding cytochrome c, mitochondrial complex I, III, IV and V and several contractile proteins. Elevated expression of antioxidant and detoxification genes appears as a dominant feature of the gene expression profile of H2O2 treated cells. Most of the genes in this category contain an Antioxidant Response Element (ARE) in their promoters. Measurements of ARE promoter-reporter gene activity indicate a dose- and time-dependent activation of the ARE by H2O2. Since the Nrf2 transcription factor regulates ARE-mediated gene expression, we overexpressed Nrf2 to test whether activation of Nrf2 is sufficient to induce cytoprotection. High levels of Nrf2 expression were achieved via adenovirus mediated gene delivery. Transduced Nrf2 was present in the nuclei and caused an increase in the expression of NAD(P)H:quinone oxidoreductase 1 (NQO1), a representative downstream target of Nrf2. Unlike H2O2 pretreated cells, the cells expressing high levels of Nrf2 were not resistant to Dox-induced apoptosis. Therefore, the cytoprotective effect of H2O2 pretreatment is not reliant upon Nrf2 activation alone as measured by resistance against Dox-induced apoptosis.
AB - Mild or low doses of oxidants are known to prime cells towards resistance against further damage. In cardiomyocytes, we found that pretreatment with 100 μM H2O2 prevents the cells from apoptosis induced by doxorubicin (Dox). Affymetrix microarray analyses of 28,000 genes reveal that H2O2 treated cells reduced expression of genes encoding cytochrome c, mitochondrial complex I, III, IV and V and several contractile proteins. Elevated expression of antioxidant and detoxification genes appears as a dominant feature of the gene expression profile of H2O2 treated cells. Most of the genes in this category contain an Antioxidant Response Element (ARE) in their promoters. Measurements of ARE promoter-reporter gene activity indicate a dose- and time-dependent activation of the ARE by H2O2. Since the Nrf2 transcription factor regulates ARE-mediated gene expression, we overexpressed Nrf2 to test whether activation of Nrf2 is sufficient to induce cytoprotection. High levels of Nrf2 expression were achieved via adenovirus mediated gene delivery. Transduced Nrf2 was present in the nuclei and caused an increase in the expression of NAD(P)H:quinone oxidoreductase 1 (NQO1), a representative downstream target of Nrf2. Unlike H2O2 pretreated cells, the cells expressing high levels of Nrf2 were not resistant to Dox-induced apoptosis. Therefore, the cytoprotective effect of H2O2 pretreatment is not reliant upon Nrf2 activation alone as measured by resistance against Dox-induced apoptosis.
KW - Antioxidant enzymes
KW - NAD(P)H:quinone oxidoreductase
KW - Nrf2 transcription factor
KW - Oxidant
UR - http://www.scopus.com/inward/record.url?scp=33845759389&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33845759389&partnerID=8YFLogxK
U2 - 10.1016/j.yjmcc.2006.09.012
DO - 10.1016/j.yjmcc.2006.09.012
M3 - Article
C2 - 17081560
AN - SCOPUS:33845759389
SN - 0022-2828
VL - 42
SP - 159
EP - 176
JO - Journal of Molecular and Cellular Cardiology
JF - Journal of Molecular and Cellular Cardiology
IS - 1
ER -